TEVA
Teva- Pharmaceutical Industries Ltd (TEVA)
Healthcare • NYSE • $35.73-0.78%
- Symbol
- TEVA
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $35.73
- Daily Change
- -0.78%
- Market Cap
- $41.60B
- Trailing P/E
- 26.66
- Forward P/E
- 11.51
- 52W High
- $37.35
- 52W Low
- $14.99
- Analyst Target
- $40.27
- Dividend Yield
- N/A
- Beta
- 0.86
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of produ…
Company websiteResearch TEVA on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.